Drug boosting “survival rates of terminally ill patients” should be here within months

Men with end-stage prostate cancer could benefit from a new drug.

Lutetium, which increased survival by four months in patients whose disease had spread, is safe and effective to use.

More than 52,000 men are diagnosed with prostate cancer each year

1

More than 52,000 men are diagnosed with prostate cancer each yearPhoto credit: Getty – Contributor

It has been approved by the Medicines and Healthcare Regulatory Agency.

The drug watchdog is expected to decide in the autumn whether to recommend an NHS rollout.

More than 52,000 men are diagnosed with prostate cancer each year and 12,000 die.

About 3,500 develop advanced disease that does not respond to routine treatment.

I'm a doctor - here are the 5 most common habits that are bad for your penis
How your LEG pain in young people could actually be a sign of common cancer

Lutetium, given intravenously, binds to cancer cells to deliver a radioactive payload that destroys the tumor.

Prof Johann de Bono of the Royal Marsden Hospital in west London said: “This is a major clinical advance.”

https://www.the-sun.com/sport/5982763/drug-prostate-cancer-survival-rate/ Drug boosting “survival rates of terminally ill patients” should be here within months

ClareFora

Daily Nation Today is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@dailynationtoday.com. The content will be deleted within 24 hours.

Related Articles

Back to top button